
Pharmaceutical cold storage operates under the strictest documentation and compliance requirements in the cold chain, because temperature excursions can compromise drug efficacy, patient safety, and regulatory approval status. From vaccine cold rooms at +2°C to +8°C through biological sample storage at -20°C and -80°C, every temperature band is governed by Good Distribution Practice (GDP), Good Manufacturing Practice (GMP), and pharmacopeia standards that require documented temperature control, qualified equipment, validated monitoring systems, and traceable construction materials. Cold rooms in pharmaceutical facilities are not just storage - they are qualified equipment that must be validated, calibrated, and maintained to a standard that proves temperature integrity to inspectors.
Pharmaceutical cold chain follows precise temperature bands defined by product stability data and regulatory standards. Refrigerated storage for vaccines, biologics, and temperature-sensitive medications holds +2°C to +8°C with tight tolerances that rarely allow excursions beyond ±2°C. Frozen storage for certain biological products and samples maintains -20°C to -25°C. Ultra-low temperature storage for mRNA vaccines and specialized biologicals operates at -60°C to -80°C. GDP, GMP, FDA 21 CFR Part 11, EU GMP Annex 15, and WHO guidelines require temperature mapping, continuous monitoring with calibrated sensors, alarm systems with escalation protocols, deviation investigation procedures, and validation documentation including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).
Pharmaceutical cold storage faces demands that set it apart from food and beverage applications:
Arteco designs pharmaceutical cold rooms with the documentation discipline the industry requires. Panel systems are specified with cleanable, non-shedding surfaces and non-flammable cores that support cleanroom-adjacent specifications. Refrigeration is sized for tight temperature control with redundancy in compressor configuration for continuous operation. Control systems integrate continuous monitoring with calibrated sensors, data logging, and alarm escalation to facility monitoring systems. Temperature mapping is planned during design, with sensor positions specified to demonstrate uniformity. Construction materials are selected for compatibility with pharmaceutical products and documented with material certifications. Layout details address pressure differentials, cleanroom interfaces, and personnel flow. Validation documentation supports IQ, OQ, and PQ protocols, with material traceability, equipment specifications, and construction records provided for qualification packages.
Material certifications, equipment specifications, construction records, and design documentation are provided to support IQ, OQ, and PQ protocols. The documentation package is structured for inclusion in facility qualification files and regulatory inspection.
Sensor positions are planned during design to demonstrate uniformity across the storage volume. We provide guidance on mapping protocols and sensor placement, and the room layout is configured to support airflow that minimizes temperature variation.
Yes. Redundant compressor configurations maintain temperature if one unit fails, with automatic switchover and alarm notification. Emergency power connections support continuity during utility interruptions. Redundancy level is specified based on product risk.
Non-flammable cores (MgO or rock wool) with cleanable steel or stainless facings are typical. Surfaces, sealants, and joint details are specified for pharmaceutical compatibility and documented with material traceability for facility records.